Activity Summary:
To further expand knowledge from Rethinking PAH Management: From Risk Assessment to Actionable Treatment Decisions, presented by Dr. Vallerie McLaughlin, HCPs can access a downloadable resources designed to reinforce and enhance information that can be utilized directly in clinical settings or for further study and reference.

Clinical Slide Deck
Downloadable PDF of presentation slides, including data visuals, algorithms, and expert insights - ideal for review, teaching, or clinical discussions.

Expert Commentary Transcript
A downloadable transcript of the podcast/video for learners who prefer text-based review or need an offline resource.

Reference and Resource Links
Direct access to featured studies, abstracts, and other kit materials cited in the program.

This activity is not designated for continuing education credit. This is in no way a reflection of the integrity or quality of the content.

Activity Summary:
Pulmonary arterial hypertension (PAH) management increasingly incorporates structured risk assessment to inform treatment decisions, yet many patients continue to remain above low-risk status despite available therapies. Clinicians must determine when risk assessment findings warrant a change in treatment, how to integrate hemodynamic and clinical data into decision-making, and how to balance disease control with treatment burden and patient preferences.

Across this podcast series, Dr. Vallerie McLaughlin shares practical, case-based insights on translating risk assessment into actionable treatment decisions. Through expert discussion and real-world clinical scenarios, the episodes examine when to escalate therapy, when continued observation may be appropriate, and when treatment simplification or de-escalation may be considered for carefully selected patients. The series also highlights shared decision-making, aligning treatment intensity with clinical need, and applying evidence-based strategies to support individualized care and improved outcomes for patients with PAH.

Activity Summary:
Pulmonary arterial hypertension (PAH) management increasingly relies on structured risk assessment to guide treatment decisions, yet many patients remain above low-risk status despite available therapies. Clinicians are often challenged with determining when risk assessment findings should prompt treatment modification, how to integrate hemodynamic and clinical data into decision-making, and how to balance disease control with treatment burden and patient preferences.

During this mini-module series, Dr. Vallerie McLauglin explores practical approaches to translating risk assessment into action. Through expert-led insights and real-world clinical cases, participants examine when to escalate therapy, when continued observation may be appropriate, and when treatment simplification or de-escalation may be considered in carefully selected patients. Particular emphasis is placed on shared decision-making, aligning treatment intensity with clinical need, and applying evidence-based strategies that support individualized care and improved outcomes for patients with PAH.

Activity Summary:
Build a practical foundation for recognizing and managing NF1-PN. These evidence-based mini-modules explores the biology and clinical presentation of NF1-PN, with a focus on early recognition, clinical decision-making, and appropriate next steps in care.

Continue exploring a collection of downloadable resources designed to support learning and clinical application from our recent activity, From Recognition to Lifelong Management in NF1-PN

Available Resources:

Downloadable Slides
Review presentation slides with key data, visuals, and clinical insights.

Reference and Resource
Access to featured studies, abstracts, and other kit materials cited in the program.

Podcast Transcript
Download the transcript for convenient text-based review anytime.

This activity is not designated for continuing education credit. This is in no way a reflection of the integrity or quality of the content.

Activity Summary:
Build a practical foundation for recognizing and managing NF1-PN. These evidence-based mini-modules explores the biology and clinical presentation of NF1-PN, with a focus on early recognition, clinical decision-making, and appropriate next steps in care.

Explore the fundamentals of recognizing and managing NF1-PN through these engaging, evidence-based podcasts. Hear expert insights on disease biology, clinical presentation, early recognition, and decision-making, including the rationale for MEK pathway targeting and key features that may warrant further evaluation or referral.

Designed for front-line clinicians, these podcasts provide practical perspectives to build confidence in recognizing NF1-PN, understanding emerging treatment approaches, and navigating early management decisions in a rapidly evolving therapeutic landscape.

Activity Summary:
To further expand knowledge from Optimizing the PAH Journey: Sequencing, Titration, and Therapy Transitions, presented by Dr. Namita Sood, HCPs can access a downloadable resources designed to reinforce and enhance information that can be utilized directly in clinical settings or for further study and reference.

Clinical Slide Deck
Downloadable PDF of presentation slides, including data visuals, algorithms, and expert insights - ideal for review, teaching, or clinical discussions.

Expert Commentary Transcript
A downloadable transcript of the podcast/video for learners who prefer text-based review or need an offline resource.

Reference and Resource Links
Direct access to featured studies, abstracts, and other kit materials cited in the program.

This activity is not designated for continuing education credit. This is in no way a reflection of the integrity or quality of the content.

Activity Summary:
Build a practical foundation for recognizing and managing NF1-PN. These evidence-based mini-modules explores the biology and clinical presentation of NF1-PN, with a focus on early recognition, clinical decision-making, and appropriate next steps in care.

Through clinical case scenarios and practical learning activities, participants will strengthen their understanding of NF1-PN pathophysiology, the rationale for MEK pathway targeting, and the clinical features that should prompt further evaluation or referral.

Designed for front-line clinicians, these foundational modules provide the knowledge and confidence to recognize NF1-PN, understand emerging treatment approaches, and navigate early management decisions in a rapidly evolving therapeutic landscape.

Activity Summary:
Continue exploring a collection of downloadable resources designed to support learning and clinical application from our recent activity, Conversations in HIV: Patient Voices Guiding Physician Choices.

Available Resources:

Downloadable Slides
Review presentation slides with key data, visuals, and clinical insights.

Podcast Transcript
Download the transcript for convenient text-based review anytime.

This activity is not designated for continuing education credit. This is in no way a reflection of the integrity or quality of the content.

Activity Summary:
The evolving PAH treatment landscape requires clinicians to make increasingly complex decisions throughout the course of patient care. From determining the most appropriate therapy and route of administration to adjusting treatment and navigating transitions, effective long-term management requires consideration of clinical response, tolerability, patient preferences, and treatment burden.

In this expert-led podcast, Dr. Namita Sood explores the practical realities of longitudinal PAH management through case-based discussion and clinical insights. Listeners will gain practical strategies for optimizing therapy through appropriate sequencing, titration, escalation, and de-escalation decisions, with a focus on navigating real-world challenges and supporting sustained treatment success for patients with PAH.

Activity Summary:
In this expert-led podcast, faculty explore the complexities of HIV care through real-world patient cases, examining the clinical, social, and individual factors that influence access to, uptake of, and persistence with antiretroviral therapy (ART).

The discussion addresses health equity and social determinants of health, long-term ART management across diverse populations, adherence and resistance considerations, and factors that may influence regimen selection and switching. Faculty also discuss strategies for preventing and managing metabolic and other comorbidities in people with HIV (PWH).

Listen in for practical, case-based insights that support individualized, patient-centered approaches to equitable and sustainable HIV care.

Activity Summary:
As the treatment landscape for pulmonary arterial hypertension (PAH) continues to evolve, clinicians face increasingly complex decisions regarding therapy sequencing, route selection, titration, and treatment transitions. Long-term success depends not only on selecting an appropriate therapy, but also on managing treatment over time while balancing efficacy, tolerability, patient preferences, and treatment burden.

Through a series of focused, case-based mini-modules, this educational activity explores the practical realities of longitudinal PAH management. Participants will gain expert insights into strategies for optimizing therapy through appropriate sequencing, titration, escalation, and de-escalation decisions.

Activity Summary:
This expert-led roundtable explores HIV care through the lens of real patient cases, examining the perspectives, concerns, and experiences that influence access to, uptake of, and persistence with antiretroviral therapy (ART). Through diverse case scenarios, experts discuss the complex factors that shape treatment decisions and long-term HIV care.

In-depth discussion focuses on health equity and social determinants of health affecting care, approaches to long-term ART management for diverse populations, and adherence and resistance considerations that may influence regimen selection and switching. The group also explores strategies for preventing and managing metabolic and other comorbidities in people with HIV (PWH), with an emphasis on individualized, patient-centered care.

Join us to engage in meaningful case-based dialogue and translate clinical insights into practical approaches that support equitable, sustainable, and comprehensive HIV care.

Activity Summary:
To further expand knowledge from From Diagnosis to Discontinuation: Rethinking the IPF Patient Experience, presented by Dr. Kevin R. Flaherty, HCPs can access a downloadable resources designed to reinforce and enhance information that can be utilized directly in clinical settings or for further study and reference.

Clinical Slide Deck
Downloadable PDF of presentation slides, including data visuals, algorithms, and expert insights - ideal for review, teaching, or clinical discussions.

Expert Commentary Transcript
A downloadable transcript of the podcast/video for learners who prefer text-based review or need an offline resource.

This activity is not designated for continuing education credit. This is in no way a reflection of the integrity or quality of the content.

Activity Summary:
Idiopathic pulmonary fibrosis (IPF) presents ongoing challenges across the patient journey, from timely diagnosis to long-term disease management. Nonspecific symptoms often delays appropriate imaging and referral, while issues related to antifibrotic tolerability and treatment discontinuation may further complicate care. Clinicians must also consider changes in physiologic measures, including DLco, alongside emerging understanding of pulmonary vascular involvement and evolving therapeutic approaches.

In this podcast, Dr. Kevin Flaherty shares expert perspectives and case-based insights on recognizing IPF earlier, optimizing antifibrotic therapy, proactively addressing adverse events, and interpreting key diagnostic and prognostic indicators. Listen in to explore strategies that can help inform timely diagnosis, individualized treatment decisions, and ongoing care for patients living with IPF.

Activity Summary:
Idiopathic pulmonary fibrosis (IPF) remains challenging to diagnose and manage in routine clinical practice. Nonspecific symptoms often delay HRCT imaging and referral, while real-world barriers such as antifibrotic tolerability and early discontinuation complicate long-term management. Clinicians must also interpret physiologic trends, including DLco decline, and integrate evolving insights into pulmonary vascular involvement and emerging therapies.

Throughout this video, Dr. Kevin Flaherty provides practical, case-based strategies to strengthen early recognition, optimize antifibrotic use, manage adverse events proactively, and interpret key diagnostic and prognostic markers. Through clinical scenarios and expert perspectives, participants will gain actionable tools to support earlier diagnosis, more personalized treatment decisions, and sustained care for patients with IPF.

Activity Summary:
To further expand knowledge from the Talking HLH: Practical Insights for Diagnosing and Managing Adult HLH, presented by Drs. Sarah Nikiforow and Daniella Schwartz, HCPs can access a variety of downloadable resources designed to reinforce and enhance information that can be utilized directly in clinical settings or for further study and reference.

Adult HLH Diagnostic and Management Algorithm
A visually structured, step-by-step clinical algorithm outlining the recommended approach to evaluating and managing suspected adult HLH.

Adult HLH Recognition and Diagnostic Quick-Reference Guide
A concise clinical reference tool summarizing early warning signs, key laboratory markers, and recommended first-line investigations for suspected adult HLH.

Clinical Slide Kit
Downloadable PDF of presentation slides, including data visuals, algorithms, and expert insights - ideal for review, teaching, or clinical discussions.

Expert Commentary Transcript
A downloadable transcript of the podcast/video for learners who prefer text-based review or need an offline resource.

Guideline & References
Links to key clinical guidelines, landmark publications, diagnostic frameworks, and educational resources related to adult HLH and hyperinflammatory syndromes

This activity is not designated for continuing education credit. This is in no way a reflection of the integrity or quality of the content.

Activity Summary:
Advances in HIV research often unfold rapidly. In order to deliver state-of-the-art care, healthcare providers who manage this patient population must stay abreast of data emerging from the major conferences.

These educational podcasts will spotlight the latest advances in the treatment and prevention of HIV and related comorbidities with a series of "what you need to know" episodes from data presented at AIDS 2026

Activity Summary:
Advances in HIV research often unfold rapidly. In order to deliver state-of-the-art care, healthcare providers who manage this patient population must stay abreast of data emerging from the major conferences.

These educational Clinical Clips will spotlight the latest advances in the treatment and prevention of HIV and related comorbidities with a series of "what you need to know" videos from data presented at AIDS 2026

Activity Summary:
Adult HLH is increasingly recognized as part of a broader hyperinflammatory spectrum, yet early diagnosis and management remain challenging in clinical practice. Because many adults present with nonspecific symptoms that overlap with sepsis, malignancy-associated inflammation, or autoimmune disease, timely recognition and treatment can be difficult.

This four-episode podcast series explores the full spectrum of adult HLH, from raising diagnostic suspicion to implementing contemporary treatment strategies. Through expert discussion and real-world clinical insights, Dr. Sarah Nikiforow and Dr. Daniella Schwartz aim to strengthen the ability to recognize HLH across diverse clinical settings, integrate biomarkers and prognostic indicators into clinical decision-making, and apply adult-specific management strategies, including emerging therapeutic options.

Activity Summary:
Adult HLH is increasingly recognized as part of a broader hyperinflammatory spectrum, yet early identification and management remain challenging in routine clinical practice. Many adult patients present with nonspecific symptoms that overlap with sepsis, malignancy-associated inflammation, or autoimmune disease, which can delay recognition and treatment.

In this series, Drs. Sarah Nikiforow and Daniella Schwartz explore the full spectrum of adult HLH, from diagnostic suspicion to modern treatment approaches. Through four episodes, this activity aims to strengthen the ability to recognize HLH across diverse clinical settings, integrate biomarkers and prognostic indicators into clinical decision-making, and apply adult-specific management strategies, including emerging therapeutic options.

Activity Summary:
To further expand knowledge from the What's New Doc? From Data to Decisions: Advancing IPF Care in 2026 presented by Dr. Steven Nathan, HCPs can access downloadable resources designed to reinforce and enhance information that can be utilized directly in clinical settings or for further study and reference.

Available Resources:

Clinical Snippet Highlights
Concise, one-page summaries of key IPF studies featured in this activity, offering quick, actionable insights to support day-to-day clinical decision-making.

Downloadable Slides
Downloadable PDF of presentation slides, including data visuals, algorithms, and expert insights - ideal for review, teaching, or clinical discussions.

Expert Commentary Transcript
A downloadable transcript of the podcast/video for learners who prefer text-based review or need an offline resource.

These resources are not designated for continuing education credit. This is in no way a reflection of the integrity or quality of the content.

Activity Summary:
To further expand knowledge from the Relapsed/Refractory Multiple Myeloma in Real Time: Practical Insights for the First Relapse, presented by Drs. Ajai Chari and Sagar Lonial, HCPs can access a variety of downloadable resources designed to reinforce and enhance information that can be utilized directly in clinical settings or for further study and reference.

Clinical Slide Kit
Downloadable PDF of presentation slides, including data visuals, algorithms, and expert insights - ideal for review, teaching, or clinical discussions.

Expert Commentary Transcripts
A downloadable transcript of the podcast/video for learners who prefer text-based review or need an offline resource.

Reference and Resources
Direct access to featured studies, abstracts, and other kit materials cited in the program.

This activity is not designated for continuing education credit. This is in no way a reflection of the integrity or quality of the content.

Activity Summary:
Advances in idiopathic pulmonary fibrosis (IPF) research continue to provide new insights into disease biology, treatment strategies, and the evolving evidence landscape. Yet, translating emerging data into clinical practice remains a challenge for many healthcare professionals.

In this podcast episode, Dr. Steven Nathan discusses the latest clinical trial findings, real-world evidence, and scientific developments shaping the current understanding of IPF. Through expert analysis and practical discussion, he explores the implications of these advances for disease management, treatment decision-making, and the future of IPF care in 2026.

Activity Summary:
Recent advances in idiopathic pulmonary fibrosis (IPF) continue to expand the evidence base, offering important insights into disease biology, therapeutic strategies, and ongoing research. However, clinicians often face challenges in interpreting and applying these insights within the context of evolving IPF care.

In this What's New Doc video, Dr. Steven Nathan reviews the latest clinical trial findings, real-world evidence, and scientific advances shaping the evolving understanding of IPF. By translating emerging data into practical clinical insights, he discusses their impact on disease management, treatment decisions, and the future direction of IPF care in 2026.

Activity Summary:
Continue exploring a collection of downloadable resources designed to support learning and clinical application from our recent activity, Conversations in HIV: Fulfilling Individual Choices to Optimize PrEP Uptake-Persistence.

Available Resources:

Downloadable Slides
Review presentation slides with key data, visuals, and clinical insights.

Podcast Transcript
Download the transcript for convenient text-based review anytime.

These resources are not designated for continuing education credit. This is in no way a reflection of the integrity or quality of the content.

Activity Summary:
Managing relapsed/refractory multiple myeloma (RRMM), particularly at first relapse, requires timely, evidence-based decisions in an increasingly complex treatment landscape. As therapeutic options continue to expand and clinical guidance evolves, healthcare professionals must navigate challenges related to risk stratification, treatment selection, sequencing strategies, and the integration of emerging immunotherapies into practice.

Clinicians may also face uncertainty in distinguishing mechanisms of action, managing immune-related toxicities, and selecting appropriate therapies in the context of treatment resistance. Additionally, real-world barriers such as staffing shortages, infusion capacity constraints, and workflow demands can complicate the implementation of optimal care. This podcast series features expert-led conversations that deliver practical insights and real-world strategies to support confident, guideline-informed decision-making in the management of RRMM.

Activity Summary:
This expert-led roundtable explores HIV prevention through the lens of real patient cases. They examine diverse scenarios, highlighting challenges and successes in implementing prevention methods such as pre-exposure prophylaxis (PrEP), safer sex practices, and regular testing.

Through in-depth discussion of these cases, the group identifies barriers to prevention, cultural and social factors influencing patient behavior, and effective communication strategies. These sessions aim to foster practical insights and improve patient-centered approaches to reduce new HIV infections in diverse populations.

Join us to engage in meaningful dialogue and translate case-based learning into impactful prevention efforts.

Activity Summary:
Relapsed/refractory multiple myeloma (RRMM) remains a complex and rapidly evolving disease state, particularly at first relapse, when timely, evidence-based decisions regarding risk stratification, treatment selection, and sequencing are essential. Healthcare professionals often face challenges keeping pace with expanding therapeutic options, emerging immunotherapies, and evolving clinical guidelines.

Many clinicians report uncertainty in differentiating mechanisms of action, managing immune-related toxicities, and optimizing treatment sequencing in the setting of emerging resistance. In addition, community and mixed-practice settings may encounter practical barriers, including staffing constraints, infusion capacity limitations, and workflow integration challenges. This mini-module series features expert-led discussions focused on practical implementation strategies to support confident, guideline-aligned decision-making and effective real-world application in RRMM care.

Activity Summary:
This expert-led roundtable explores HIV prevention through the lens of real patient cases. They examine diverse scenarios, highlighting challenges and successes in implementing prevention methods such as pre-exposure prophylaxis (PrEP), safer sex practices, and regular testing.

Through in-depth discussion of these cases, the group identifies barriers to prevention, cultural and social factors influencing patient behavior, and effective communication strategies. These sessions aim to foster practical insights and improve patient-centered approaches to reduce new HIV infections in diverse populations.

Join us to engage in meaningful dialogue and translate case-based learning into impactful prevention efforts.

Activity Summary:
Continue exploring a collection of downloadable resources designed to support learning and clinical application from our recent activity, From Refractory to Resolved: Rethinking Uncontrolled Gout in 2026 with Dr. Robert Terkeltaub.

Available Resources:

Downloadable Slides
Review presentation slides with key data, visuals, and clinical insights.

Podcast Transcript
Download the transcript for convenient text-based review anytime.

References & Resources
A list of key studies, abstracts, and materials featured in the activity.

This activity is not designated for continuing education credit. This is in no way a reflection of the integrity or quality of the content.